Louisiana Digital News

Amgen: Appeal Becomes Visible Despite Uncertainty On The “Horizon” (NASDAQ:AMGN)


Amgen sign at its headquarters in Thousand Oaks, California, USA.


In February, I concluded that the re-rating of Amgen (NASDAQ:AMGN) looked fair, after shares fell 15% since the announcement of the acquisition of Horizon Therapeutics (HZNP). This looked fair amidst a strong share price performance beforehand, high leverage

Source link

Leave A Reply

Your email address will not be published.